Description

PT-141 (Bremelanotide) is a peptide originally developed to treat sexual dysfunction. It works by activating melanocortin receptors in the brain, which are involved in sexual arousal. Unlike other treatments that act on the vascular system, PT-141 targets the central nervous system to enhance libido and improve sexual expression in both men and women.

Chat with one of the doctors at MD Plus to find out what this peptide might be able to do for you.

Typical dosing is 5 to 15 units subcutaneously, administered approximately one hour prior to anticipated sexual activity. It is best to start with the lowest dose to assess tolerance, as some individuals may experience nausea or flushing. Gradually titrate upward to achieve the desired effect.

Disclaimer: This therapy is not FDA-approved. The use of PT-141 is based on anecdotal evidence and clinical experience in the wellness and optimization field. It has not been studied or approved for safety or effectiveness by the U.S. Food and Drug Administration.